annual operating expenses:
$11.99B-$423.48M(-3.41%)Summary
- As of today (August 17, 2025), TAK annual total operating expenses is $11.99 billion, with the most recent change of -$423.48 million (-3.41%) on March 1, 2025.
- During the last 3 years, TAK annual operating expenses has fallen by -$764.97 million (-6.00%).
- TAK annual operating expenses is now -12.33% below its all-time high of $13.67 billion, reached on March 31, 2020.
Performance
TAK Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$3.72B-$236.74M(-5.99%)Summary
- As of today (August 17, 2025), TAK quarterly total operating expenses is $3.72 billion, with the most recent change of -$236.74 million (-5.99%) on June 1, 2025.
- Over the past year, TAK quarterly operating expenses has dropped by -$483.53 million (-11.51%).
- TAK quarterly operating expenses is now -43.88% below its all-time high of $6.62 billion, reached on March 31, 2011.
Performance
TAK quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TAK Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.4% | -11.5% |
| 3 y3 years | -6.0% | -9.0% |
| 5 y5 years | -12.3% | +0.9% |
TAK Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.0% | at low | -30.8% | +8.6% |
| 5 y | 5-year | -12.3% | at low | -30.8% | +8.6% |
| alltime | all time | -12.3% | +633.1% | -43.9% | +528.9% |
TAK Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $3.72B(-6.0%) |
| Mar 2025 | $11.99B(-3.4%) | $3.95B(-19.6%) |
| Dec 2024 | - | $4.92B(+43.7%) |
| Sep 2024 | - | $3.42B(-18.6%) |
| Jun 2024 | - | $4.20B(+18.4%) |
| Mar 2024 | $12.41B(+2.6%) | $3.55B(-33.9%) |
| Dec 2023 | - | $5.37B(+3.6%) |
| Sep 2023 | - | $5.18B(+25.0%) |
| Jun 2023 | - | $4.15B(+18.9%) |
| Mar 2023 | $12.10B(-5.1%) | $3.49B(-19.9%) |
| Dec 2022 | - | $4.35B(+1.5%) |
| Sep 2022 | - | $4.29B(+5.0%) |
| Jun 2022 | - | $4.08B(-1.5%) |
| Mar 2022 | $12.75B(+0.1%) | $4.14B(-6.4%) |
| Dec 2021 | - | $4.43B(+3.4%) |
| Sep 2021 | - | $4.28B(+2.0%) |
| Jun 2021 | - | $4.20B(-2.9%) |
| Mar 2021 | $12.74B(-6.9%) | $4.32B(+2.5%) |
| Dec 2020 | - | $4.22B(-8.8%) |
| Sep 2020 | - | $4.63B(+25.6%) |
| Jun 2020 | - | $3.68B(+0.5%) |
| Mar 2020 | $13.67B(+43.5%) | $3.67B(-24.2%) |
| Dec 2019 | - | $4.84B(+8.8%) |
| Sep 2019 | - | $4.45B(-4.6%) |
| Jun 2019 | - | $4.66B(-2.7%) |
| Mar 2019 | $9.53B(+10.8%) | $4.79B(+117.4%) |
| Dec 2018 | - | $2.20B(-0.5%) |
| Sep 2018 | - | $2.22B(+4.9%) |
| Jun 2018 | - | $2.11B(-46.2%) |
| Mar 2018 | $8.60B(+0.1%) | $3.92B(+71.8%) |
| Dec 2017 | - | $2.28B(-6.8%) |
| Sep 2017 | - | $2.45B(+105.7%) |
| Jun 2017 | - | $1.19B(-66.2%) |
| Mar 2017 | $8.59B(+4.7%) | $3.53B(+46.8%) |
| Dec 2016 | - | $2.40B(-7.6%) |
| Sep 2016 | - | $2.60B(+92.8%) |
| Jun 2016 | - | $1.35B(-51.1%) |
| Mar 2016 | $8.21B(-3.9%) | $2.76B(+16.8%) |
| Dec 2015 | - | $2.36B(+10.8%) |
| Sep 2015 | - | $2.13B(-6.1%) |
| Jun 2015 | - | $2.27B(-57.1%) |
| Mar 2015 | $8.54B | $5.30B(+127.2%) |
| Dec 2014 | - | $2.33B(-6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $2.48B(+10.6%) |
| Jun 2014 | - | $2.25B(-28.2%) |
| Mar 2014 | $9.14B(-10.3%) | $3.13B(+20.5%) |
| Dec 2013 | - | $2.59B(+4.7%) |
| Sep 2013 | - | $2.48B(+4.0%) |
| Jun 2013 | - | $2.38B(-32.8%) |
| Mar 2013 | $10.19B(+10.8%) | $3.54B(+20.1%) |
| Dec 2012 | - | $2.95B(+0.9%) |
| Sep 2012 | - | $2.92B(+0.8%) |
| Jun 2012 | - | $2.90B(-9.3%) |
| Mar 2012 | $9.19B(+7.1%) | $3.20B(+9.6%) |
| Dec 2011 | - | $2.92B(-17.3%) |
| Sep 2011 | - | $3.53B(+398.5%) |
| Jun 2011 | - | $707.58M(-89.3%) |
| Mar 2011 | $8.58B(+4.7%) | $6.62B(+731.1%) |
| Dec 2010 | - | $796.76M(+10.3%) |
| Sep 2010 | - | $722.23M(+7.0%) |
| Jun 2010 | - | $674.97M(-88.9%) |
| Mar 2010 | $8.19B(-12.6%) | $6.08B(+640.7%) |
| Dec 2009 | - | $820.31M(+8.4%) |
| Sep 2009 | - | $756.49M(+13.6%) |
| Jun 2009 | - | $665.85M(-89.0%) |
| Mar 2009 | $9.37B(+59.1%) | $6.04B(+921.9%) |
| Dec 2008 | - | $590.92M(-26.6%) |
| Sep 2008 | - | $805.39M |
| Mar 2008 | $5.89B(+21.4%) | - |
| Mar 2007 | $4.85B(+4.1%) | - |
| Mar 2006 | $4.66B(+9.2%) | - |
| Mar 2005 | $4.27B(+8.2%) | - |
| Mar 2004 | $3.94B(+10.4%) | - |
| Mar 2003 | $3.57B(+15.5%) | - |
| Mar 2002 | $3.09B(+8.9%) | - |
| Mar 2001 | $2.84B(-1.1%) | - |
| Mar 2000 | $2.87B(+36.7%) | - |
| Mar 1999 | $2.10B(-8.1%) | - |
| Mar 1998 | $2.28B(-1.7%) | - |
| Mar 1997 | $2.32B(-12.2%) | - |
| Mar 1996 | $2.65B(+4.9%) | - |
| Mar 1995 | $2.52B(+7.6%) | - |
| Mar 1994 | $2.35B(+16.0%) | - |
| Mar 1993 | $2.02B(+14.3%) | - |
| Mar 1992 | $1.77B(+8.2%) | - |
| Mar 1991 | $1.64B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total operating expenses?
- What is the all time high annual operating expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual operating expenses year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly operating expenses year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total operating expenses?
The current annual operating expenses of TAK is $11.99B
What is the all time high annual operating expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total operating expenses is $13.67B
What is Takeda Pharmaceutical Company Limited annual operating expenses year-on-year change?
Over the past year, TAK annual total operating expenses has changed by -$423.48M (-3.41%)
What is Takeda Pharmaceutical Company Limited quarterly total operating expenses?
The current quarterly operating expenses of TAK is $3.72B
What is the all time high quarterly operating expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total operating expenses is $6.62B
What is Takeda Pharmaceutical Company Limited quarterly operating expenses year-on-year change?
Over the past year, TAK quarterly total operating expenses has changed by -$483.53M (-11.51%)